Incidence of colorectal cancer at different screening intervals after index colonoscopy and post-polypectomy: a meta-analysis of 811,181 participants

Expert Rev Gastroenterol Hepatol. 2022 Nov-Dec;16(11-12):1101-1114. doi: 10.1080/17474124.2022.2147925. Epub 2022 Nov 23.

Abstract

Objectives: To examine the evidence on the incidence of colorectal cancers (CRCs) at a follow-up screening colonoscopy (after index colonoscopy and post-polypectomy) in individuals with no adenoma, low-risk adenomas, and high-risk adenomas.

Methods: We included studies reporting the incidence of CRCs at different screening intervals after index colonoscopy and post-polypectomy. The main outcome was pooled cumulative incidence rate of CRCs stratified by intervals of 3, 5, 10, and >10 years.

Results: Fourteen studies with 811,181 participants were analyzed, including 10 multicenter studies and 3 national CRC screening programs. The cumulative incidence of CRCs was 0.63% (95% confidence interval [CI]: 0.30, 0.97) in the high-risk-adenoma group at 3 years, 0.37% (95% CI: 0.13, 0.61) and 0.67% (95% CI: 0.36, 0.99) in the low-risk-adenoma group at 5 and 10 years, respectively, and 0.32% (95% CI: 0.20, 0.45) and 0.50% (95% CI: 0.30, 0.69) in the no-adenoma-group at 10 and >10 years, respectively.

Conclusion: This meta-analysis summarizes the results of colonoscopy surveillance programs with detailed data support for different screening intervals. The data on date suggest that reasonable surveillance intervals are within 3 years for the high-risk-adenoma group, 5-10 years for the low-risk-adenoma group, and ≥10 years for the no-adenoma group.

Keywords: Colorectal neoplasms; colonoscopy; colorectal cancer screening; endoscopic polypectomy; meta-analysis.

Publication types

  • Meta-Analysis

MeSH terms

  • Adenoma* / diagnosis
  • Adenoma* / epidemiology
  • Adenoma* / surgery
  • Colonoscopy / adverse effects
  • Colorectal Neoplasms* / diagnosis
  • Colorectal Neoplasms* / epidemiology
  • Colorectal Neoplasms* / surgery
  • Early Detection of Cancer / methods
  • Humans
  • Incidence
  • Risk Factors